This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
 
Markets End Higher Monday, Despite Dow's Earlier Triple-Digit Drop

Stocks managed to end Monday's session in the green, despite the Dow's triple digit losses earlier in the trading session.

Will China's Q3 GDP Figures Show Its Economy is Stalling?

The Chinese government is set to release Q3 GDP figures on Tuesday morning but figures below expectations could trigger more volatility in the markets.

A New Survey Says Pay Raises Are Rarer Despite Strong U.S. Hiring

U.S. businesses were much less likely to boost pay in the third quarter than in previous months, even as hiring remained healthy.

Canadian Pacific Ends CSX Deal Talks Amid Merger Regulations

Canadian Pacific Railway says it has ended talks with U.S. counterpart CSX about a possible combination.

Boeing Revises Schedule For Air Force Tanker to Stay on Schedule

Boeing is revising its schedule for developing its new KC-46A Pegasus aerial tanker for the U.S. Air Force, but says that won't cause it to miss a key delivery deadline.

Real Money Previews

Real Money's Kate Stalter: Strategizing Your Retirement Fund

Don't stampede into cash at this stage.

Cramer Reviews His Top 10 List for a Market Recovery: Boxes Checked!

We now have an investable bottom on our hands.

Look Down!; Jump of a Lifetime; Not for the Faint of Heart: Best of Kass

In highlights from his trading diary of the past week, Doug Kass writes about how investors aren't looking in the right direction and frustration with such a volatile market.

Mad Money Recap

'Mad Money' Lightning Round: Lots of Ways to Win With Molson Coors

Cramer is avoiding SeaDrill and Silicon Graphics but likes Gilead and Mettler-Toledo.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

How to Trade the Market's Most-Active Stocks

Here's how to trade some of the most active stocks on the market right now.

4 Huge Stocks on Traders' Radars

Here's how to trade some of the most active stocks on the market today.

5 Hated Earnings Stocks You Should Love

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

5 Rocket Stocks to Buy for Earnings Season Gains

These stock shave both short-term gain catalysts and longer-term growth potential.

5 Stocks Ready to Break Out and Soar Higher

These stocks look ready to break out and trade higher from current levels.

MainStreet

Fees in Your Retirement Account Are Higher Than You May Think

Most people surveyed believe they are paying no fees at all.

SEC Busts First-Ever High Frequency Trader in Market Manipulation Scam

The stock manipulation case dates back to 2009 but just received enforcement action.

You Can Ruin Your Retirement If You're Living In This State

Where you spend your golden years has a big influence on the happiness you experience in retirement.

Why Geopolitical Risk Could Actually Be Good For Your Portfolio

The turmoil in the world isn't all bad news.

Biotech

First Detailed Look at Celgene Crohn's Disease Pill Impresses

As a pill, Celgene's GED-031 (also known as mongersen) has the potential to become a preferred Crohn's therapy over injectable drugs like Abbvie's top-selling Humira.

Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents

Biotech columnist Adam Feuerstein answers readers' questions about health care.

Brainstorm CEO Offers Investors a Frank Outlook for ALS Therapy

Given the usual hype surrounding small-cap biotechs, Brainstorm CEO Tony Fiorino is refreshingly candid about the company's chances of developing a stem-cell treatment to counter ALS symptoms.

Beyond Wall St.

Deal News

Apple Supplier GT Advanced Set for Key Hearing Tomorrow

The diversified technology company looks to shutter its sapphire plants and to keep certain information under seal.

Canadian Pacific Ends CSX Deal Talks Amid Merger Regulations

Canadian Pacific Railway says it has ended talks with U.S. counterpart CSX about a possible combination.

A More Attractive Cleco Goes to Infrastructure Investor Group for $4.7 Billion

After it got no traction with a sale process last year, an unsolicited bid kicks off an auction.

TheStreetTV
Spin Space

Jim Cramer

Cramer Reviews His Top 10 List for a Market Recovery: Boxes Checked!

We now have an investable bottom on our hands.

Herb Greenberg

Greenberg on the Stock Market: Why Investigations No Longer Matter

I can't remember the last time a company got more than a slap on the wrist.

Stephanie Link

Stephanie Link: You Can Still Find Value in this Pullback

Action Alerts PLUS has been buying into it.

Chris Ciaccia

Apple Q4 Earnings Focus On the iPhone and Slowing iPad Growth: Live Blog

Apple has had a busy several weeks, with the launch of the new products, but eyes will be on the company's earnings and its outlook for the all-important holiday season.

Adam Feuerstein

First Detailed Look at Celgene Crohn's Disease Pill Impresses

As a pill, Celgene's GED-031 (also known as mongersen) has the potential to become a preferred Crohn's therapy over injectable drugs like Abbvie's top-selling Humira.

Dan Freed

More People Have Jobs But Wages Are Stagnant, Says Moody's Lonski

Moody's Analytics Chief Market Economist John Lonski says employment numbers show more people finding work, but pay mostly stagnant.

Ted Reed

Delta to Wall Street: Don't Tell Us How to Run Our Airline

Delta is widely seen as the leading U.S. airline, yet some Wall Street analysts have decided it is adding too much capacity, breaking the mold of 'capacity discipline.'

Leon Lazaroff

Lions Gate Joins Online Video Party in Deal With Tribeca

Lions Gate is joining with Tribeca Enterprises as more TV and movie producers seek to start online subscription services.

Submit an article to us!
DOW 16,399.67 +19.26 0.12%
S&P 500 1,904.01 +17.25 0.91%
NASDAQ 4,316.0740 +57.6360 1.35%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs